Showing 921-930 of 2942 results for "".
Headache in Dysautonomia & “Long COVID”/PASC
https://practicalneurology.com/diseases-diagnoses/headache-pain/headache-in-dysautonomia-long-covidpasc/31899/Frequent and long-lasting headaches are a common symptom of autonomic disorders and long COVID / postacute sequelae of SARS-CoV-2 infection (PASC).Immune-Mediated Cerebellar Ataxias
https://practicalneurology.com/diseases-diagnoses/movement-disorders/immune-mediated-cerebellar-ataxias/31708/Cerebellar ataxia may be a prominent feature in autoimmune encephalitis and paraneoplastic syndromes.Comorbidity Disparities in Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/comorbidity-disparities-in-multiple-sclerosis/31763/Comorbid diseases that are often more prevalent in underserved groups have large effects on multiple sclerosis prognosis.Sleep & Neurodegenerative Disease
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/sleep--neurodegenerative-disease/30108/Sleep problems are common and treatable in neurodegenerative disorders, and may also be a treatable risk factor and early biomarker.Immunopathogenesis of Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/immunopathogenesis-of-multiple-sclerosis/30127/Disruption of immune tolerance, inflammation, and blood-brain–barrier breach lead to demyelination and axonal injury.Artificial Intelligence in Clinical Neurology: Opportunities, Limitations, and the Path Forward
https://practicalneurology.com/diseases-diagnoses/imaging-testing/artificial-intelligence-in-clinical-neurology-opportunities-limitations-and-the-path-forward/56386/Artificial intelligence is revolutionizing clinical neuroimaging by enhancing how neurologic conditions are diagnosed, prioritized, and managed, but its challenges must be addressed to ensure safe and fair use across diverse patient populations.Neuromyelitis Optica Spectrum Disorders
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/neuromyelitis-optica-spectrum-disorders/30129/It is critical to maintain a high index of suspicion for these conditions when evaluating a patient with demyelination to avoid delays in treatment.Resumption of Anticoagulant Therapy Following Ischemic and Hemorrhagic Strokes: Indications and Timing
https://practicalneurology.com/diseases-diagnoses/stroke/resumption-of-anticoagulant-therapy-following-ischemic-and-hemorrhagic-strokes-indications-and-timing/31965/Resumption of anticoagulant in ischemic stroke or intracranial hemorrhage should be individualized.Beyond the Binary: Rethinking Stroke Prevention in Atrial Fibrillation With Cerebral Amyloid Angiopathy
https://practicalneurology.com/diseases-diagnoses/stroke/beyond-the-binary-rethinking-stroke-prevention-in-atrial-fibrillation-with-cerebral-amyloid-angiopathy/54791/Neurocardiac programs can integrate imaging-informed risk stratification, comorbidity-focused research, and emerging biomarkers to guide atrial fibrillation management in people with cerebral amyloid angiopathy.Clarifying the Role of Vitamin D in Multiple Sclerosis Risk and Prevention
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/clarifying-the-role-of-vitamin-d-in-multiple-sclerosis-risk-and-prevention/30314/Recent findings reinforce the link between vitamin D levels and risk of multiple sclerosis.